Resistance inCampylobacterSpecies: Increased Resistance to Fluoroquinolones and Seasonal Variation
Author(s) -
E. Talsma,
Wim Goettsch,
H. L. J. Nieste,
Paul Schrijnemakers,
M Sprenger
Publication year - 1999
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/520447
Subject(s) - campylobacteriosis , campylobacter , enrofloxacin , veterinary medicine , ofloxacin , tetracycline , erythromycin , medicine , campylobacter jejuni , ciprofloxacin , feces , campylobacter coli , antibiotic resistance , microbiology and biotechnology , biology , antibiotics , bacteria , genetics
To identify epidemiological features of culture-proven campylobacter infections and to determine resistance rates, we conducted a 4-year demographic survey of culture-proven campylobacteriosis in one Dutch region. Examination of 24,435 fecal specimens revealed 1,315 cases of campylobacteriosis (5.4%). The ofloxacin-resistance rate among Campylobacter isolates increased from 11% to 29%. Resistance against tetracycline fluctuated between 7% and 15%, and resistance against erythromycin remained low. Resistance against fluoroquinolones was seasonally influenced, with relatively high rates during winter. We conclude that resistance of Campylobacter isolates to fluoroquinolones is still rising, probably because of the use of fluoroquinolones (enrofloxacin) in animal husbandry.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom